Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPBWR1 | P48145 | 5/20 | 0.64 |
| ▸ | IL23R | Q5VWK5 | 14/20 | 0.59 |
| ▸ | CCKAR | P32238 | 1/20 | 0.58 |
| ▸ | CCKBR | P32239 | 1/20 | 0.58 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31105518 | 0.96 | NPBWR1 (0.68) | NPBWR1IL23R | |
| SCHEMBL29555469 | 0.93 | NPBWR1 (0.66) | NPBWR1IL23R | |
| SCHEMBL30518077 | 0.92 | IL23R (0.64) | NPBWR1IL23R | |
| SCHEMBL30518175 | 0.91 | IL23R (0.67) | NPBWR1IL23R | |
| SCHEMBL30518071 | 0.91 | NPBWR1 (0.64) | NPBWR1IL23RCCKARCCKBROPRD1 | |
| SCHEMBL30518169 | 0.91 | NPBWR1 (0.62) | NPBWR1IL23R | |
| SCHEMBL30092947 | 0.91 | IL23R (0.59) | NPBWR1IL23R | |
| SCHEMBL30518095 | 0.90 | NPBWR1 (0.64) | NPBWR1IL23R | |
| SCHEMBL30518037 | 0.90 | IL23R (0.67) | NPBWR1IL23R | |
| SCHEMBL30518165 | 0.90 | NPBWR1 (0.64) | NPBWR1IL23R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260078144-A1 | ACTIVE PEPTIDE, AND COMPOSITION AND USE THEREOF | WINKEY TECH USA INC (US) | 2026-03-19 | — | — | US | claimed |
| WO-2024217503-A1 | ACTIVE PEPTIDE, AND COMPOSITION AND USE THEREOF | 深圳市维琪科技股份有限公司 | 2024-10-24 | — | — | WO | claimed |
| CN-116535463-A | Active peptide, composition and use thereof | 深圳市维琪科技股份有限公司 | 2023-08-04 | — | — | CN | claimed |
| US-20260078144-A1 | ACTIVE PEPTIDE, AND COMPOSITION AND USE THEREOF | WINKEY TECH USA INC (US) | 2026-03-19 | — | — | US | disclosed |
| WO-2024217503-A1 | ACTIVE PEPTIDE, AND COMPOSITION AND USE THEREOF | 深圳市维琪科技股份有限公司 | 2024-10-24 | — | — | WO | disclosed |
| CN-117343140-B | Active peptide, composition and use thereof | 深圳市维琪科技股份有限公司 | 2024-09-20 | — | — | CN | disclosed |
| CN-117343140-A | Active peptide, composition and use thereof | 深圳市维琪科技股份有限公司 | 2024-01-05 | — | — | CN | disclosed |
| CN-116535463-B | Active peptide, composition and use thereof | 深圳市维琪科技股份有限公司 | 2023-10-31 | — | — | CN | disclosed |
| CN-116535463-A | Active peptide, composition and use thereof | 深圳市维琪科技股份有限公司 | 2023-08-04 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260078144-A1 | ACTIVE PEPTIDE, AND COMPOSITION AND USE THEREOF | ARGLU1, ARG1, POT1 | NPBWR1 71/4885IL23R 4196/4885CCKAR 1063/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.